Pascal Krotee
Principal at RiverVest Venture Partners
San Diego, California
Overview
Work Experience
Principal
2023 - Current
Senior Associate
2021 - 2023
Member Board of Directors
2023
Board Observer
2021 - 2023
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Raised $242,239,990.00 from Arkin Bio Ventures, RA Capital Management, T. Rowe Price, RiverVest, Frazier Life Sciences, Novo Holdings, Octagon Capital Advisors, Unicorn Capital Partners, HBM Healthcare Investments and Wellington Management.
Board of Directors
2019 - 2021
Holoclara is a immunotherapy company that offers autoimmune disorders with nematode derived molecules.
Raised $16,000,000.00 from Tarrasque, Horizons Ventures, Endurance28, Bold Capital Partners and Freeflow Ventures.
Board of Directors
2019 - 2021
Board of Directors
2019 - 2021
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
Raised $25,461,307.00 from Penn Medicine Co-Investment Program and Kairos Ventures.
Investment Associate
2017 - 2021
Kairos Ventures invests in ideas, patents, and businesses from universities and scientists.
Contract Consultant
2015 - 2017
Teacher
2014 - 2017
Junior Specialist
2010 - 2011
Undergraduate Research Assistant
2006 - 2010